Groupe Oncologie Radiotherapie Tete et Cou   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Tours France (1999)

Organization Overview

First Clinical Trial
2000
NCT00158652
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Groupe Oncologie Radiotherapie Tete et Cou